Can-Fite BioPharma announces Q2 financial results for 2015.

For the convenience of the reader, the reported NIS quantities have been translated into U.S. Dollars, at the representative price of exchange on June 30, 2015 . The Firm'june 30 s consolidated financial statements for the six months ended, 2015 are presented relative to International Financial Reporting Requirements.. Can-Fite BioPharma announces Q2 financial results for 2015, updates drug development programs Can-Fite BioPharma Ltd. , a biotechnology firm with a pipeline of proprietary little molecule drugs being developed to treat inflammatory diseases, tumor and sexual dysfunction, today reported financial results for the six months ended June 30, 2015 and updates on its drug advancement programs.S.The researchers expect that knowledge allows plants to be employed more regularly in the creation of therapeutic proteins, a significant type of medication. Related StoriesImproved gene therapy treatment displays guarantee in mice with cystic fibrosisScalable creation of gene therapy vectors: an interview with Frank UbagsPerisylvian polymicrogyria gene foundThe discovery ties in with technology produced by the Wageningen UR study institute Plant Analysis International for the creation of biopharmaceuticals in vegetation. Proteins in plants, people and animals include various sugars chains in an activity known as glycosylation. The glucose chains are of significance to the working of several proteins.

Other articles from category "urology":

Random articles